The Abacavir Hypersensitivity Reaction (ABC HSR) educational programme has the following aims:

  • Maintaining low morbidity and mortality from ABC HSR in general, and to minimise the risk of ABC rechallenge in patients with clinically suspected HSR, regardless of HLA-B*5701 status.
  • Increase understanding and awareness of ABC HSR by Healthcare professionals (HCPs) and expand on the information already included in the product labels.
  • Increase awareness of ABC HSR by patients via the ABC HSR Alert/Warning card and product labelling.